U.S. Physical Therapy, Inc. (USPH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $1.49B
Last updated: Nov 17, 2026 at 11:05 AM ET
U.S. Physical Therapy, Inc. (USPH) Earnings: Report Dates and Results
U.S. Physical Therapy (USPH) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, U.S. Physical Therapy reported EPS of $0.80, above the $0.76 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
USPH has an expected report date of Feb 23, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 34.3% above the $0.67 reported for the quarter ended Dec 31, 2025.
USPH Earnings Call
The latest USPH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, USPH beat 23, missed 14 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $222.56M, up 12.9% from $197.13M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.80 | $0.76 | $0.57 - $0.90 | +5.26% | Beat | +21.2% | 6 | 1 up, 1 down | Nov 4, 2026 | $222.56M |
| Jun 30, 2026 | $0.75 | $0.85 | $0.78 - $0.91 | -11.76% | Miss | -7.4% | 5 | 0 up, 0 down | Aug 5, 2026 | $214.06M |
| Mar 31, 2026 | $0.46 | $0.52 | $0.35 - $0.64 | -11.54% | Miss | -4.2% | 7 | 0 up, 0 down | May 6, 2026 | $198.29M |
| Dec 31, 2025 | $0.67 | $0.67 | $0.61 - $0.73 | -0.56% | Miss | +31.4% | 6 | 1 up, 0 down | Feb 25, 2026 | $202.73M |
| Sep 30, 2025 | $0.66 | $0.67 | $0.59 - $0.73 | -1.49% | Miss | -4.3% | 5 | 3 up, 1 down | Nov 5, 2025 | $197.13M |
| Jun 30, 2025 | $0.81 | $0.69 | $0.62 - $0.78 | +17.39% | Beat | +11.0% | 5 | 0 up, 6 down | Aug 6, 2025 | $197.34M |
| Mar 31, 2025 | $0.48 | $0.45 | $0.34 - $0.63 | +6.67% | Beat | -5.9% | 6 | 0 up, 4 down | May 7, 2025 | $183.79M |
| Dec 31, 2024 | $0.51 | $0.70 | $0.56 - $0.77 | -26.78% | Miss | -13.6% | 7 | 2 up, 3 down | Feb 26, 2025 | $180.45M |
| Sep 30, 2024 | $0.69 | $0.68 | $0.61 - $0.73 | +1.47% | Beat | +11.3% | 6 | 0 up, 0 down | Nov 5, 2024 | $168.03M |
| Jun 30, 2024 | $0.73 | $0.82 | $0.74 - $0.89 | -10.98% | Miss | -3.9% | 6 | 0 up, 0 down | Aug 13, 2024 | $167.19M |
| Mar 31, 2024 | $0.51 | $0.56 | $0.46 - $0.67 | -8.93% | Miss | -13.6% | 6 | 0 up, 0 down | May 7, 2024 | $155.68M |
| Dec 31, 2023 | $0.59 | $0.57 | $0.48 - $0.66 | +3.51% | Beat | +1.7% | 6 | 0 up, 0 down | Feb 28, 2024 | $154.80M |
| Sep 30, 2023 | $0.62 | $0.62 | $0.56 - $0.66 | 0.00% | In line | +6.9% | 6 | 0 up, 0 down | Nov 7, 2023 | $150.01M |
| Jun 30, 2023 | $0.76 | $0.75 | $0.71 - $0.80 | +1.33% | Beat | -15.6% | 5 | 0 up, 0 down | Aug 8, 2023 | $151.49M |
| Mar 31, 2023 | $0.59 | $0.55 | $0.49 - $0.62 | +7.27% | Beat | -9.2% | 4 | 0 up, 0 down | May 3, 2023 | $148.51M |
| Dec 31, 2022 | $0.58 | $0.57 | $0.54 - $0.62 | +1.75% | Beat | -19.4% | 4 | 0 up, 0 down | Feb 22, 2023 | $141.18M |
| Sep 30, 2022 | $0.58 | $0.56 | $0.48 - $0.60 | +3.57% | Beat | -31.8% | 5 | 1 up, 0 down | Nov 2, 2022 | $139.60M |
| Jun 30, 2022 | $0.90 | $0.95 | N/A | -5.26% | Miss | -6.2% | N/A | 0 up, 0 down | Aug 4, 2022 | $140.66M |
| Mar 31, 2022 | $0.65 | $0.63 | $0.60 - $0.66 | +3.17% | Beat | +1.6% | 4 | 0 up, 1 down | May 5, 2022 | $131.70M |
| Dec 31, 2021 | $0.72 | $0.69 | $0.65 - $0.71 | +4.35% | Beat | -15.3% | 5 | N/A | Feb 24, 2022 | $129.83M |
| Sep 30, 2021 | $0.85 | $0.78 | $0.73 - $0.85 | +8.97% | Beat | 0.0% | 5 | N/A | Nov 4, 2021 | $125.89M |
| Jun 30, 2021 | $0.96 | $0.71 | $0.68 - $0.79 | +35.21% | Beat | +146.2% | 5 | N/A | Aug 5, 2021 | $126.93M |
| Mar 31, 2021 | $0.64 | $0.47 | $0.24 - $0.58 | +36.17% | Beat | +113.3% | 5 | N/A | May 6, 2021 | $112.37M |
| Dec 31, 2020 | $0.85 | $0.83 | $0.71 - $0.89 | +2.41% | Beat | +32.8% | 5 | N/A | Feb 25, 2021 | $117.47M |
| Sep 30, 2020 | $0.85 | $0.51 | $0.40 - $0.67 | +66.67% | Beat | +19.7% | 5 | N/A | Nov 5, 2020 | $108.93M |
| Jun 30, 2020 | $0.39 | -$0.18 | -$0.28 - -$0.06 | +316.67% | Beat | -51.9% | 4 | N/A | Aug 6, 2020 | $83.86M |
| Mar 31, 2020 | $0.30 | $0.32 | $0.04 - $0.72 | -6.25% | Miss | -54.5% | 5 | N/A | May 21, 2020 | $112.72M |
| Dec 31, 2019 | $0.64 | $0.69 | $0.67 - $0.70 | -7.25% | Miss | -9.9% | 6 | N/A | Feb 27, 2020 | $122.11M |
| Sep 30, 2019 | $0.71 | $0.71 | $0.70 - $0.72 | 0.00% | In line | +10.9% | 6 | N/A | Nov 7, 2019 | $117.25M |
| Jun 30, 2019 | $0.81 | $0.81 | $0.79 - $0.82 | 0.00% | In line | +68.8% | 6 | N/A | Aug 8, 2019 | $126.37M |
| Mar 31, 2019 | $0.66 | $0.61 | $0.58 - $0.62 | +8.20% | Beat | +144.4% | 6 | N/A | May 2, 2019 | $116.23M |
| Dec 31, 2018 | $0.71 | $0.63 | $0.59 - $0.64 | +12.70% | Beat | +44.9% | 6 | N/A | Mar 7, 2019 | $109.56M |
| Sep 30, 2018 | $0.64 | $0.58 | $0.55 - $0.60 | +10.34% | Beat | +33.3% | 7 | N/A | Nov 1, 2018 | $113.12M |
| Jun 30, 2018 | $0.48 | $0.68 | $0.64 - $0.70 | -29.41% | Miss | -18.6% | 7 | N/A | Aug 2, 2018 | $115.10M |
| Mar 31, 2018 | $0.27 | $0.56 | $0.52 - $0.61 | -51.79% | Miss | -43.7% | 7 | N/A | May 3, 2018 | $116.13M |
| Dec 31, 2017 | $0.49 | $0.47 | $0.38 - $0.52 | +4.26% | Beat | +6.5% | 7 | N/A | Mar 8, 2018 | $134.03M |
| Sep 30, 2017 | $0.48 | $0.49 | $0.42 - $0.55 | -2.04% | Miss | +4.3% | 7 | N/A | Nov 2, 2017 | $103.03M |
| Jun 30, 2017 | $0.59 | $0.56 | $0.54 - $0.64 | +5.36% | Beat | +3.5% | 7 | N/A | Aug 3, 2017 | $104.25M |
| Mar 31, 2017 | $0.48 | $0.47 | $0.43 - $0.50 | +2.13% | Beat | +11.6% | 6 | N/A | Jun 7, 2017 | $97.56M |
| Dec 31, 2016 | $0.46 | $0.47 | $0.45 - $0.49 | -2.13% | Miss | -4.2% | 6 | N/A | Mar 2, 2017 | $98.57M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $2.62, up 7.4% from the year before. It was $1.92 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $2.62 | +7.4% |
| Dec 31, 2024 | $2.44 | -4.7% |
| Dec 31, 2023 | $2.56 | -5.5% |
| Dec 31, 2022 | $2.71 | -14.5% |
| Dec 31, 2021 | $3.17 | +32.6% |
| Dec 31, 2020 | $2.39 | -15.2% |
| Dec 31, 2019 | $2.82 | +34.3% |
| Dec 31, 2018 | $2.10 | +2.9% |
| Dec 31, 2017 | $2.04 | +6.3% |
| Dec 31, 2016 | $1.92 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,600 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,559 | 11 | |
| 2026Q2 | Jun 30, 2026 | 6,000 | 10 | |
| 2026Q1 | Mar 31, 2026 | 4,436 | 10 | |
| 2025Q4 | Dec 31, 2025 | 9,511 | 12 | |
| 2025Q3 | Sep 30, 2025 | 1,814 | 11 | |
| 2025Q2 | Jun 30, 2025 | 7,708 | 12 | |
| 2025Q1 | Mar 31, 2025 | 2,725 | 10 | |
| 2024Q4 | Dec 31, 2024 | 8,645 | 12 |
2026Q3 Earnings Call
Opening remarks
Christopher Reading Chairman and CEO Good morning, and welcome to U.S. Physical Therapy's third quarter 2026 earnings call. With me today are Nchacha Etta, our EVP and new Chief Financial Officer; Eric Williams, President and COO East; Graham Reeve, COO West; Rick Binstein, our General Counsel; and Jason Curtis, our Senior Vice President of Accounting and Finance. Before we get started, Jason will read our disclosure statement. Jason, if you would, please.
Jason Curtis Senior Vice President of Accounting and Finance Thank you, Chris. The presentation includes forward-looking statements, which involve certain risks and uncertainties. These forward-looking statements are based on the company's current views and assumptions. The company's actual results may vary materially from those anticipated. Please see the company's filings with the Securities and Exchange Commission for more information. This presentation also includes certain non-GAAP measures as defined in Regulation G, and the related reconciliation can be found in the company's earnings release and the company's presentation on our website.
Christopher Reading Chairman and CEO Thanks, Jason. This is Nchacha's first earnings call with us. He has been on many during a distinguished public company career. Nchacha, welcome. We are thrilled to have you, and we look forward to introducing you more personally to our analysts and shareholders in the days ahead. As always, I want to start by thanking our partners and our clinical and support teams. Their work changes lives for our patients across our physical therapy partnerships. It also keeps employees healthy and on the job at many of our nation's largest and most successful employers through our injury prevention teams. Our physical therapy business starts with great care, and that care delivers real value to the broader health care system. Even for Medicare-age patients, completing an outpatient physical therapy plan of care is associated with lower total health care spending the following year, according to a study commissioned by APTQI in 2017 and independently performed by the Maran Group. Great care is what lets us grow volume every year across a growing clinic base. This quarter is often a seasonally softer quarter as referral sources and staff vacations kick in. But we held steady this summer at more than 33 visits per clinic per day right through the quarter, compared with 32 a year ago. We set a couple of important records this quarter. With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred—nearly 2.5 years of record volume each and every month. We did this while our operations and clinical teams completed a very major lift in this third quarter. All of the Metro New York facilities moved into our NYU Langone relationship, and the majority of that lift occurred in the third quarter.
Frequently Asked Questions About USPH
When is U.S. Physical Therapy's next earnings date?
U.S. Physical Therapy's next earnings report is expected for Feb 23, 2027.
Did USPH beat earnings estimates last quarter?
Yes. U.S. Physical Therapy reported EPS of $0.80 for the quarter ended Sep 30, 2026, above the $0.76 estimate, a 5.26% surprise.
What EPS do analysts expect from USPH next quarter?
The consensus EPS estimate for U.S. Physical Therapy for the quarter ending Dec 31, 2026 is $0.90 from 9 analysts, with estimates from $0.76 to $1.04.
How often does USPH beat earnings estimates?
U.S. Physical Therapy beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -2.85%.
USPH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors